The United States Judicial Panel on Multidistrict Litigation recently ruled in favor of consolidating 18 class action lawsuits currently pending against Abbott Laboratories in response to contamination found in batches of infant formula. The discovery of the contamination led to nationwide shortages of the formula. At the height of the crisis, nearly 30% of the nation’s infant formula supply showed as out of stock.
The ...
continue reading...
Abbott Labs and the Food and Drug Administration plan to authorize the
As shortages worsen across the nation, a federal investigation into the source of tainted infant formula has so far yielded
A judicial panel has approved a request by Abbott Laboratories to consolidate cases alleging that the